The 2nd annual 3D Tissue Models 2017 revealed the very latest advances in bioengineering and 3D cell culturing helping attendees to strengthen the predictability and interpretation of model-based research within preclinical development.
Attendees witnessed large pharma and leading academics demonstrating how to apply 3D models to improve the selection and validation of target molecules through more robust efficacy predictions, greater accuracy in safety measurements, and more representative disease modeling.
3D Tissue Models 2017 saw critical questions answered with attendees learning the true utility and limitations of these models in pharmaceutical development, helping them to overcome key drug development, biological and cultural challenges to achieve rapid success in their organizations.
"The depth of the discussion, and opportunities to hear perspectives from those leading the industry on developing 3D tissue models made this an exceptionally valuable meeting"
Commercial Innovation Life Sciences Lead Center for the Advancement of Science in Space